Among its most controversial provisions, the Act radically redefines how inventorship is determined and authorizes unprecedented post-grant review procedures. Advocates of the Act argue that such provisions are necessary to improve patent quality and to reduce the crushing backlog of unexamined patents at the U.S. Patent Office.
However, it is imperative that patent applicants, whether they are large multinationals, small start-ups, universities, or even individual inventors, be aware of how the Act has changed the U.S. patent system so they may appropriately update their existing patent strategies.
The complete article in IP Today is available here.
More information about Intellectual Property at Baker Botts is available here.
Steve Lendaris’ bio is available here.
About Baker Botts L.L.P.
Baker Botts is an international law firm with over 725 lawyers and a network of 13 offices around the globe. Based on our experience and knowledge of our clients’ industries, we are recognized as a leading firm in the energy, technology and life sciences sectors. Throughout our 170-year history, we have provided creative and effective legal solutions for our clients while demonstrating an unrelenting commitment to excellence. For more information, please visit www.bakerbotts.com.